614 related articles for article (PubMed ID: 33291351)
1. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.
Pinto B; Henriques AC; Silva PMA; Bousbaa H
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33291351
[TBL] [Abstract][Full Text] [Related]
2. Three-Dimensional Spheroids for Cancer Research.
Tutty MA; Prina-Mello A
Methods Mol Biol; 2023; 2645():65-103. PubMed ID: 37202612
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans ET; Doijen J; Luyten W; Landuyt B; Schoofs L
J Cell Physiol; 2018 Apr; 233(4):2993-3003. PubMed ID: 28618001
[TBL] [Abstract][Full Text] [Related]
4. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
5. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles.
Abreu TR; Biscaia M; Gonçalves N; Fonseca NA; Moreira JN
Adv Exp Med Biol; 2021; 1295():271-299. PubMed ID: 33543464
[TBL] [Abstract][Full Text] [Related]
7. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
8. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.
Daunys S; Janonienė A; Januškevičienė I; Paškevičiūtė M; Petrikaitė V
Adv Exp Med Biol; 2021; 1295():243-270. PubMed ID: 33543463
[TBL] [Abstract][Full Text] [Related]
9. 3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies.
Shi H; Rath EM; Lin RCY; Sarun KH; Clarke CJ; McCaughan BC; Ke H; Linton A; Lee K; Klebe S; Maitz J; Song K; Wang Y; Kao S; Cheng YY
Front Oncol; 2022; 12():973576. PubMed ID: 36091141
[TBL] [Abstract][Full Text] [Related]
10. 3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro.
Brancato V; Gioiella F; Imparato G; Guarnieri D; Urciuolo F; Netti PA
Acta Biomater; 2018 Jul; 75():200-212. PubMed ID: 29864516
[TBL] [Abstract][Full Text] [Related]
11. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
Singh M; Close DA; Mukundan S; Johnston PA; Sant S
Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
[TBL] [Abstract][Full Text] [Related]
12. Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs.
Moskovits N; Itzhaki E; Tarasenko N; Chausky E; Bareket-Samish A; Kaufman A; Meerson R; Stemmer SM
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591992
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
14. Could 3D models of cancer enhance drug screening?
Brancato V; Oliveira JM; Correlo VM; Reis RL; Kundu SC
Biomaterials; 2020 Feb; 232():119744. PubMed ID: 31918229
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
van Rijt A; Stefanek E; Valente K
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
[TBL] [Abstract][Full Text] [Related]
16. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
Ferreira LP; Gaspar VM; Mano JF
Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
[TBL] [Abstract][Full Text] [Related]
17. Application of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system research.
Huang BW; Gao JQ
J Control Release; 2018 Jan; 270():246-259. PubMed ID: 29233763
[TBL] [Abstract][Full Text] [Related]
18. Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance.
Shehzad A; Ravinayagam V; AlRumaih H; Aljafary M; Almohazey D; Almofty S; Al-Rashid NA; Al-Suhaimi EA
Curr Pharm Des; 2019; 25(34):3599-3607. PubMed ID: 31612821
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids.
Yau JNN; Yempala T; Muthuramalingam RPK; Giustarini G; Teng G; Ang WH; Gibson D; Adriani G; Pastorin G
Adv Healthc Mater; 2024 May; ():e2400203. PubMed ID: 38774999
[TBL] [Abstract][Full Text] [Related]
20. Tumor spheroids and organoids as preclinical model systems.
Baniahmad A
Med Genet; 2021 Sep; 33(3):229-234. PubMed ID: 38835698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
